Back
Capricor Therapeutics Stock Price Chart
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72
CAPR
Capricor Therapeutics
Last Price:
21.53
Seasonality Move:
-24.28%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.47 | Buy |
| 20-day SMA: | 8.85 | Buy |
| 50-day SMA: | 6.05 | Buy |
| 200-day SMA: | 5.35 | Buy |
| 8-day EMA: | 15.11 | Buy |
| 20-day EMA: | 10.74 | Buy |
| 50-day EMA: | 7.52 | Buy |
| 200-day EMA: | 5.55 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.52 | Buy |
| Relative Strength Index (14 RSI): | 94.61 | Buy |
| Chaikin Money Flow: | 8515375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.86 - 13.02) | Buy |
| Bollinger Bands (100): | (2.66 - 8.54) | Buy |
Capricor Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 21.65 while CAPR 8-day simple moving average is 14.47, which is a Buy signal.
- The stock price of CAPR is 21.65 while Capricor Therapeutics 20-day SMA is 8.85, which makes it a Buy.
- Capricor Therapeutics 50-day simple moving average is 6.05 while CAPR share price is 21.65, making it a Buy technically.
- CAPR stock price is 21.65 and Capricor Therapeutics 200-day simple moving average is 5.35, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Buy
72
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a Buy
The current Capricor Therapeutics [CAPR] share price is $21.65. The Score for CAPR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
704.47M
Price in USD:
21.65
Share Volume:
9.99M
Capricor Therapeutics 52-Week Range
52-Week High:
21.98
52-Week Low:
2.68
Buy
72
Capricor Therapeutics (CAPR)
is a Buy
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?
The Capricor Therapeutics stock price is 21.65 USD today. -
Will CAPR stock go up or go down?
Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Capricor Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is not overvalued.
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 21.65 while CAPR 8-day exponential moving average is 15.11, which is a Buy signal.
- The stock price of CAPR is 21.65 while Capricor Therapeutics 20-day EMA is 10.74, which makes it a Buy.
- Capricor Therapeutics 50-day exponential moving average is 7.52 while CAPR share price is 21.65, making it a Buy technically.
- CAPR stock price is 21.65 and Capricor Therapeutics 200-day simple moving average is 5.55, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.69 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
- CAPR Moving Average Covergence Divergence (MACD) indicator is 3.52, suggesting Capricor Therapeutics is a Buy
- Capricor Therapeutics Relative Strength Index (RSI) is 94.61, which suggest Capricor Therapeutics is overbought
- The Bollinger Bands (25) for Capricor Therapeutics is (2.86 - 13.02), which suggest Capricor Therapeutics is a Buy
- The Bollinger Bands (100) for Capricor Therapeutics is (2.66 - 8.54), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.